Skip to main content

Tag: FDA

DEA Rushes Dangerous, Addictive ADHD Drugs to Market to Meet Demand

October 31, 2024

Alert the media! Get Dan Rather on the phone! The United States of America is having a problem producing enough legal, yet highly addictive, and dangerous, mind-altering drugs that are alleged to “treat” attention deficit hyperactivity disorder (ADHD).

The Drug Enforcement Administration (DEA), the federal agency that oversees drug distribution of Controlled Substances, is responsible for setting quotas and controlling the amount of drug that may be legally produced. In this case, there apparently was a shortfall of ADHD medications in 2022 because there was an enormous increase in the diagnosis of ADHD during the Covid Pandemic and the pharmaceutical manufacturers failed to produce the full amount of approved drug, causing a one billion dose shortfall for 2023 and the great catch-up ensued. One billion doses. Geesh! A billion here and a billion there and pretty soon we’re talking about real drugging!

Continue reading

Psychiatric Drug Cocktails: Risky Experiments on Human Minds

October 9, 2024

Photo by Jen Theodore on Unsplash

Despite zero understanding of how even one psychiatric drug “works” as “treatment” for alleged mental disorders, the rate of cocktail (polypharmacy) drugging among children is increasing. One doctor called for informed consent about the benefits and risks associated with the “contraindicated” drugging.

A recent study from Lawrence Kleinman, professor of pediatrics at Rutgers Robert Wood Johnson Medical School, reviewed Medicaid data for more than 141,000 patients (under 21) receiving any psychiatric medication and found that nearly 400 of those patients received at least one “potentially dangerous combination” of psychiatric drugs.

Dr. Kleinman warned that “good practice demands that patients and caregivers be informed of and assent to risks and benefits, including informing them that the intended pair of medications is typically contraindicated.” What Kleinman is warning is that there are serious risks to prescribing cocktails of psychiatric drugs and it is not recommended.

Continue reading

FDA Responds to AbleChild’s MedWatch PSA Request for Public Education

Recently, AbleChild requested that the FDA run their own PSA (Public Service Announcement) to educate the public on how to report Adverse Drug Reactions directly to the Agency.  The FDA’s response to our request is shocking, as they state that because MedWatch is a “voluntary” program, there is no need to run the PSA to educate the people on its existence and importance.

Continue reading

FDA’s MedWatch Minute, Where has it been?

AbleChild found a 2016 Public Service Announcement on the Consumer Adverse Drug Reporting System.  One must ask, why hasn’t this been running on TV?  With the billion dollar drug industry advertising on TV, it is amazing that this FDA PSA hasn’t seen the light of day.  This is exactly why we need a urgent call to action to get a MedWatch law passed for the consumers.

We need your help, please take action  Please support our efforts to keep informed consent mission going!

Continue reading

Internal FDA Documents Link Mind Altering Psychiatric Drugs to Murder

Rare documents, that are kept far from the public view, expose the knowledge the FDA has regarding the link between mind altering psychiatric drugs and murder.

Below are internal documents that were collected through the MEDWATCH reporting system on adverse drug events collected by the FDA and obtained by Parents Against Pharma by a Freedom of Information Request. (FOIA)

These documents illustrate the importance of educating the public on the MedWatch Adverse Drug Reporting System and the known link between mind-altering psychiatric drugs and increase risk of homicide.

AbleChild vs. Chief Medical Examiner in Connecticut was the case in front of the Freedom of Information Commission in the aftermath Sandy Hook requesting the release of Adam Lanza’s mental health records, toxicology, and autopsy reports.  AbleChild submitted FDA findings in our filing.

In addition, these documents should be provided to every lawmaker to increase consumer protection laws on informed consent in the “loosely” regulated field of mental health that places us all in danger.

ParentsAgainstPharma
FDA MedWatch Prozac
FDA Prozac MedWatch2

PostMarketing
Highlights
Vyvanse FDA MedWatch
Redacted2
LINK TO MURDER FDA Nortrityline
LINK TO MURDER FDA
RedactedProsac4
Redacted

Poster boy, Tj – 8 year old, used in op-ed to sell more mental illness in CT

More mental illness screening, more mental illness care, more mental illness services, more mental illness diagnosing, and more mental illness treatment.  This is what the op-ed of May 26th titled:  Review of Children’s mental healthcare is vital, demands, yet nowhere in the piece does the writer discuss the psychiatric drug “therapy” utilized in mental health’s “treatment” regimen for T.J., the subject of the piece.

Reportedly eight year-old T.J. was diagnosed with the alleged brain abnormality, Attention Deficit Hyperactivity Disorder, ADHD, because he had problems focusing in school and was hyperactive.  T.J. received mental health services in another state.  At what age did T.J. first receive these “services?”  The writer does not say.

What exactly were those “services?”  Was T.J. “treated” with Ritalin or Adderall? Both highly addictive drugs and, according to the Drug Enforcement Administration, DEA  nearly identical to cocaine. Or, perhaps, T.J. had been prescribed the “non-stimulant” drug Strattera, a Selective Serotonin Reuptake Inhibitor, SSRI.

SSRI’s are the most commonly prescribed form of antidepressant, yet approved by the Food and Drug Administration, FDA, for the “treatment” of the alleged ADHD.  Ironically, it also is the FDA who plastered “Black Box” warnings – the agency’s most serious warning – on these drugs because they may cause abnormal thoughts and suicidal behavior in children.

Remember it is the National Institute of Mental Health, NIMH, that openly admits scientists have no idea what causes the alleged ADHD.  And the pharmaceutical companies openly admit on the product packaging that they don’t know how the drugs work in the brain to “treat” the alleged ADHD.  Frankly this drug “treatment” is one big guessing game, and the kids, at extremely young ages, are being used as guinea pigs.

This is the problem with crying for more mental illness services. There is no science to support even one psychiatric diagnosis. There is no known objective, confirmable abnormality that is a psychiatric diagnosis.  It is completely subjective.  The American Psychiatric Association, APA, merely has gathered lists of behaviors and randomly decided they equate to some mental illness that needs to be “treated.”

Columbine, Aurora. Co., and Sandy Hook, to name a few, all were the result of young men with long histories of mental health “treatment.” Now in the wake of yet another mass murder in Santa Barbara, where the shooter openly discusses his years-long psychiatric “treatment,” it seems incredible that the state of Connecticut is rushing to implement increased mental illness services when, in fact, lawmakers should be investigating the very dangerous psychiatric drugs used as “treatments.” To paraphrase the lyrics of Pink Floyd’s The Wall, “hey, psychiatrists, leave them kids alone!”

At the end of the day, PA-13-178  which the op-ed writer “endorses,” is based on the recommendations made by mental health vendors who clearly have a horse in the race. Lawmakers should acknowledge the obvious conflict of interest and mandate that these vendors will not benefit from their increased mental illness services recommendations.

If these mental illness vendor “stops” are not put in place, where will the power to label the state’s children as “abnormal,” and drug them into submission, end?